Substance use: a powerful predictor of relapse in schizophrenia
The DOI matches its Crossref record; 23 of the 26 references it cites were found in a registry or an index.
Abstract
This study examined substance use among a group of 37 schizophrenia patients participating in a year-long fluphenazine decanoate (FD; Prolixin) dosage reduction study (Inderbitzin et al. (1994) Am. J. Psychiatry 151, 1753-1759). Ten (50%) of the 20 FD dose-reduced patients, and 6 (35%) of the 17 control group patients were identified as substance users. The dose-reduced and control groups did not differ significantly in substance use. We examine here the 37 patients regrouped by substance users (n = 16) versus non-users (n = 21) to determine the effects of substance use. In addition to identifying substance users and types of substances used, we hypothesize that substance users differ demographically from non-users, have worse symptomatology, worse compliance, higher rates of relapse, and therefore, can confound studies. Clinical and demographic data were obtained. At least half of the substance users were using alcohol or cocaine. The substance use group had a significantly higher severity of illness score on the BPRS at study onset. We found no significant differences between the two groups on other rating scales. The non-use group lived more independently, and the substance use group was younger. The substance use group had nearly twice as many hospitalizations in the 2 years prior to the study, a greater rate of missed appointments in the year before and during the study, and 4 times as many relapses during the year of the study than the non-use group. The key finding was…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over 50% of people diagnosed with a severe mental illness, such as schizophrenia or bipolar disorder, will meet criteria for a substance use disorder in their lifetime.”
From Mobile intervention for individuals with psychosis, dual disorders, and their common comorbidities: A literature review (2019) · cites this paper as [8]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“A doctoral research psychologist was trained to perform all other assessments, the Brief Psychiatric Rating Scale (BPRS) (Overall and Gorham, 1962), Scale for the Assessment of Negative Symptoms (Andreasen, 1984a), Scale for the Assessment of Positive Symptoms (Andreasen, 1984b), and Hamilton Psychiatric Rating Scale…”
Method- STATISTICAL PACKAGE FOR SOCIAL SCIENCES
(2014) · Statistical Methods in Psychiatry Research and SPSS · doi:10.1201/b17560-26 · Cited by 12,056
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090 · cited 1×
“A doctoral research psychologist was trained to perform all other assessments, the Brief Psychiatric Rating Scale (BPRS) (Overall and Gorham, 1962), Scale for the Assessment of Negative Symptoms (Andreasen, 1984a), Scale for the Assessment of Positive Symptoms (Andreasen, 1984b), and Hamilton Psychiatric Rating Scale…”
MethodRegier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Scale for Assessment of Positive Symptoms (SAPS) 1984
Andreasen, N. C. (1995) · Open Scholarship Institutional Repository (Washington University in St. Louis) · Cited by 2,423
Alcohol Use and Abuse in Schizophrenia: A Prospective Community Study
DRAKE, R. E., OSHER, F. C., & WALLACH, M. A. (1989) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198907000-00004 · Cited by 470
Substance Abuse Among the Chronic Mentally Ill
Drake, R. E., & Wallach, M. A. (1989) · Psychiatric Services · doi:10.1176/ps.40.10.1041 · Cited by 417
Cited by
Implementing Dual Diagnosis Services for Clients With Severe Mental Illness
Drake, R. E., Essock, S. M., Shaner, A., Carey, K. B., Minkoff, K., Kola, L., Lynde, D., Osher, F. C., Clark, R. E., & Rickards, L. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.4.469 · Cited by 693
“Second, dual diagnosis is associated with a variety of negative outcomes, including higher rates of relapse (4), hospitalization (5), violence (6), incarceration (7), homelessness (8), and serious infections such as HIV and hepatitis (9).”
BackgroundMueser, K. T., Drake, R. E., & Wallach, M. A. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00073-2 · Cited by 617
Review of Integrated Mental Health and Substance Abuse Treatment for Patients With Dual Disorders
Drake, R. E., Mercer-McFadden, C., Mueser, K. T., McHugo, G. J., & Bond, G. R. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033351 · Cited by 596
“Prospective studies have shown that treatment outcomes, such as symptom levels, hospitalization rates, housing stability, and functional status, are worse among patients with dual disorders than among those who have single disorders (Drake et al. 1989; Linszen et al. 1994; Osher et al. 1994; Chouljian et al. 1995; Swo…”
BackgroundOperational criteria and factors related to recovery from schizophrenia
Liberman, R. P., Kopelowicz, A., Ventura, J., & Gutkind, D. (2002) · International Review of Psychiatry · doi:10.1080/0954026021000016905 · Cited by 495
“Patients who use drugs or alcohol have been found to be more symptomatic while hospitalized, relapse more frequently, have poorer psychosocial functioning, and to have poorer prognoses for recovery (Cleghorn et al., 1991; Bowers et al., 1990; Tsuang et al., 1982; Swofford et al., 1996).”
BackgroundDrake, R. E., Mueser, K. T., Brunette, M. F., & McHugo, G. J. (2004) · Psychiatric Rehabilitation Journal · doi:10.2975/27.2004.360.374 · Cited by 459
Metadata
- Authors
- Swofford, C. D., Kasckow, J. W., Scheller-Gilkey, G., & Inderbitzin, L. B.
- Affiliations
- Grady Memorial Hospital (US)
- Emory University (US)
- Corresponding author
- Swofford, Cheryl D.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 1996-05
- Volume
- 20
- Issue
- 1-2
- Pages
- 145-151
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2014347408
- Cited by
- 247
- References
- 26
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 6 · 2019: 6 · 2018: 9 · 2017: 9 · 2016: 3 · 2015: 4 · 2014: 10 · 2013: 13 · 2012: 10
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- substance use, schizophrenia
- MeSH terms
- Adult, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Fluphenazine, Humans, Male, Middle Aged, Patient Compliance, Prognosis, Psychotropic Drugs, Recurrence, Schizophrenia, Schizophrenic Psychology, Illicit Drugs, Antipsychotic Agents, Comorbidity, Diagnosis, Dual (Psychiatry), Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Substance use: a powerful predictor of relapse in schizophrenia. https://app.cochat.ai/papers/10.1016/0920-9964(95)00068-2
- The paper
- Swofford, C. D., Kasckow, J. W., Scheller-Gilkey, G., & Inderbitzin, L. B. (1996). Substance use: a powerful predictor of relapse in schizophrenia. Schizophrenia Research. https://doi.org/10.1016/0920-9964(95)00068-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.